Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293101926> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4293101926 endingPage "2882" @default.
- W4293101926 startingPage "2872" @default.
- W4293101926 abstract "Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious disease caused by porcine reproductive and respiratory syndrome virus (PRRSV), which causes great economic losses. At the moment, no effective neutralizing antibody is available for scientific research and treatment. Therefore, developing a method for screening the neutralizing monoclonal antibodies is of great significance for the prevention and treatment of PRRSV and the screening of antigen sites. Monoclonal antibodies have been widely used in the treatment and diagnosis of many human and animal diseases. Therefore, screening effective neutralizing antibodies for different pathogens is an urgent task. Among the methods for monoclonal antibody screening, B cell immortalization is an effective method to obtain neutralizing monoclonal antibody. Specifically, in this study, the bcl-6 and bcl-xl genes were connected by f2a and then the yielded product was ligated to a vector for retrovirus packaging. The swine lymphocytes immunized with PRRSV were infected the yielded mature viruses and cultured in the complete medium containing CD40L and IL21 cytokines. Then, CD21 was used as the marker to screen B cells with the magnetic bead method. Finally, monoclonal B cells were obtained and the secretion of antibodies was tested. The results showed that the plasmid, either being transfected alone or with the packaged plasmids, could be expressed, and that the packaged retrovirus could infect the cells. Moreover, the infected lymphocytes secreted antibodies, so did the screened B cells. Therefore, the method for screening monoclonal antibody against PRRSV was successfully established." @default.
- W4293101926 created "2022-08-26" @default.
- W4293101926 creator A5000137718 @default.
- W4293101926 creator A5017262243 @default.
- W4293101926 creator A5017947172 @default.
- W4293101926 creator A5022226638 @default.
- W4293101926 creator A5032764121 @default.
- W4293101926 creator A5036990231 @default.
- W4293101926 creator A5038336303 @default.
- W4293101926 creator A5042352041 @default.
- W4293101926 creator A5056036725 @default.
- W4293101926 creator A5056986875 @default.
- W4293101926 creator A5061247586 @default.
- W4293101926 creator A5063917782 @default.
- W4293101926 creator A5070589231 @default.
- W4293101926 creator A5091164712 @default.
- W4293101926 date "2022-08-25" @default.
- W4293101926 modified "2023-09-27" @default.
- W4293101926 title "[A method for immortalizing swine monoclonal B cells secreting anti-PRRSV antibodies]." @default.
- W4293101926 doi "https://doi.org/10.13345/j.cjb.210856" @default.
- W4293101926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36002416" @default.
- W4293101926 hasPublicationYear "2022" @default.
- W4293101926 type Work @default.
- W4293101926 citedByCount "0" @default.
- W4293101926 crossrefType "journal-article" @default.
- W4293101926 hasAuthorship W4293101926A5000137718 @default.
- W4293101926 hasAuthorship W4293101926A5017262243 @default.
- W4293101926 hasAuthorship W4293101926A5017947172 @default.
- W4293101926 hasAuthorship W4293101926A5022226638 @default.
- W4293101926 hasAuthorship W4293101926A5032764121 @default.
- W4293101926 hasAuthorship W4293101926A5036990231 @default.
- W4293101926 hasAuthorship W4293101926A5038336303 @default.
- W4293101926 hasAuthorship W4293101926A5042352041 @default.
- W4293101926 hasAuthorship W4293101926A5056036725 @default.
- W4293101926 hasAuthorship W4293101926A5056986875 @default.
- W4293101926 hasAuthorship W4293101926A5061247586 @default.
- W4293101926 hasAuthorship W4293101926A5063917782 @default.
- W4293101926 hasAuthorship W4293101926A5070589231 @default.
- W4293101926 hasAuthorship W4293101926A5091164712 @default.
- W4293101926 hasConcept C104317684 @default.
- W4293101926 hasConcept C147483822 @default.
- W4293101926 hasConcept C159047783 @default.
- W4293101926 hasConcept C159654299 @default.
- W4293101926 hasConcept C203014093 @default.
- W4293101926 hasConcept C22744801 @default.
- W4293101926 hasConcept C2522874641 @default.
- W4293101926 hasConcept C2778431562 @default.
- W4293101926 hasConcept C2779819720 @default.
- W4293101926 hasConcept C542903549 @default.
- W4293101926 hasConcept C55493867 @default.
- W4293101926 hasConcept C86803240 @default.
- W4293101926 hasConceptScore W4293101926C104317684 @default.
- W4293101926 hasConceptScore W4293101926C147483822 @default.
- W4293101926 hasConceptScore W4293101926C159047783 @default.
- W4293101926 hasConceptScore W4293101926C159654299 @default.
- W4293101926 hasConceptScore W4293101926C203014093 @default.
- W4293101926 hasConceptScore W4293101926C22744801 @default.
- W4293101926 hasConceptScore W4293101926C2522874641 @default.
- W4293101926 hasConceptScore W4293101926C2778431562 @default.
- W4293101926 hasConceptScore W4293101926C2779819720 @default.
- W4293101926 hasConceptScore W4293101926C542903549 @default.
- W4293101926 hasConceptScore W4293101926C55493867 @default.
- W4293101926 hasConceptScore W4293101926C86803240 @default.
- W4293101926 hasIssue "8" @default.
- W4293101926 hasLocation W42931019261 @default.
- W4293101926 hasOpenAccess W4293101926 @default.
- W4293101926 hasPrimaryLocation W42931019261 @default.
- W4293101926 hasRelatedWork W1487857142 @default.
- W4293101926 hasRelatedWork W1679554208 @default.
- W4293101926 hasRelatedWork W1968017175 @default.
- W4293101926 hasRelatedWork W1968866496 @default.
- W4293101926 hasRelatedWork W1974843652 @default.
- W4293101926 hasRelatedWork W2017080314 @default.
- W4293101926 hasRelatedWork W2064089409 @default.
- W4293101926 hasRelatedWork W2076922394 @default.
- W4293101926 hasRelatedWork W2213278224 @default.
- W4293101926 hasRelatedWork W2768045426 @default.
- W4293101926 hasVolume "38" @default.
- W4293101926 isParatext "false" @default.
- W4293101926 isRetracted "false" @default.
- W4293101926 workType "article" @default.